APOE rs2477637: Understanding This Genetic Variant
The rs2477637 variant is a genetic marker located in the region of the APOE gene, which is well-known for its role in lipid metabolism and neurological health. Research suggests this specific variant may be associated with variations in lipid profiles and indicators of healthy aging, though the evidence remains limited.
What each genotype means
Typical healthspan and lipid profile
You carry two copies of the common C allele at rs2477637 near APOE. In population research, this baseline genotype is associated with standard age-related lipid metabolism and average parental lifespan trends. Because this variant is located near major APOE haplotype markers, its independent statistical effect remains modest and limited.
Carried by approximately 70% to 75% of individuals in European populations, and is the predominant genotype worldwide.
Intermediate longevity association
You carry one copy of the minor T allele at rs2477637. Observational studies in European cohorts have linked this allele to small variations in circulating lipid fractions and modest differences in longevity metrics, such as parental survival. However, evidence remains limited and these statistical associations are largely influenced by linkage with broader APOE genetic patterns.
Found in roughly 25% of individuals of European descent, with lower frequencies generally reported in East Asian populations.
Altered lipid and survival marker
You carry two copies of the minor T allele at rs2477637. Genome-wide association analyses associate this genotype with shifts in lipid parameters and parental lifespan metrics compared to the baseline CC genotype. These population findings reflect subtle statistical tendencies rather than direct causal effects, and evidence for an independent clinical impact is limited.
Carried by approximately 2% to 3% of individuals of European ancestry and is rare across most other continental populations.
What is rs2477637?
The rs2477637 variant is a single nucleotide polymorphism (SNP) situated in the genomic region of the APOE gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. While many people are familiar with the APOE gene due to its famous variants that influence Alzheimer's disease risk, rs2477637 is a distinct marker located downstream of the primary coding regions. Because it is not a coding mutation that changes the structure of the APOE protein itself, it is often studied for its potential role in regulating gene expression or as a marker that tracks with other functional variations in the area. Scientists use such markers to map out how different segments of our DNA contribute to complex traits like metabolism and longevity.
The Role of the APOE Gene
The APOE gene provides instructions for making apolipoprotein E, a protein that combines with fats in the body to form lipoproteins. These lipoproteins are essential for packaging cholesterol and other fats and carrying them through the bloodstream. Because cholesterol cannot travel through the blood on its own, these transporters are vital for maintaining healthy lipid levels. Beyond lipid transport, the APOE protein plays a significant role in the nervous system, where it helps repair damaged neurons and clear away cellular debris. Given its central role in both cardiovascular and brain health, variations in or near the APOE gene are frequently investigated for their influence on how we age and our susceptibility to age-related conditions.
Research and Evidence Strength
Current research into rs2477637 characterizes it as a variant with limited evidence regarding its direct impact on health outcomes. While the broader APOE region is strongly linked to lipid metabolism and longevity, the specific contribution of rs2477637 is less clear. Some studies have explored its association with lipid profiles, such as cholesterol and triglyceride levels, as well as broader healthspan indicators. However, it is important to note that genetic associations are often complex and can vary significantly between different populations. Because the evidence for this specific SNP is not as robust as that for other well-known APOE variants, it is considered a subject of ongoing investigation rather than a definitive predictor of health. Researchers continue to analyze large datasets to determine if this marker holds clinical significance.
Population Frequency
Genetic variants are distributed differently across the globe, and rs2477637 is no exception. In European populations, the minor allele frequency for this variant is approximately 0.15, meaning it is present in a notable portion of the population but is not the most common form. Frequency data is essential for researchers because it helps them understand the evolutionary history of a variant and its potential impact on public health. If a variant is common, it may have been maintained in the population over time, whereas rare variants are often studied for their specific, sometimes high-impact, effects on disease risk. Understanding these frequencies helps scientists contextualize findings from genome-wide association studies.
Interpreting Your Genetic Information
If you have received information about your rs2477637 genotype, it is important to view it within the context of your overall health. Genetic markers like this one provide only a small piece of a much larger puzzle that includes your lifestyle, environment, and other genetic factors. You cannot use this information to diagnose a condition or predict your future health with certainty. If you are concerned about your lipid levels or your long-term healthspan, the most effective approach is to consult with a healthcare professional. They can interpret your clinical blood work and family history to provide personalized guidance. Never make changes to your diet, exercise, or medication based solely on a genetic report; always discuss your results and any health goals with your doctor or a qualified genetic counselor.
How common is this variant?
The minor allele frequency for rs2477637 is approximately 0.15 in European populations, indicating it is a relatively common variant.
Frequently asked questions
Is rs2477637 the same as the APOE4 Alzheimer's risk gene?
No, rs2477637 is a different genetic marker located in the APOE region. It should not be confused with the well-known variants that define the APOE4 isoform, which are strongly associated with Alzheimer's disease risk.
Can I use this SNP to predict my cholesterol levels?
No, this SNP cannot be used to predict your cholesterol levels. While it has been studied in the context of lipid metabolism, your actual cholesterol levels are determined by a complex combination of your diet, lifestyle, and many other genetic factors.
Should I change my diet based on my rs2477637 result?
You should not change your diet based on this genetic result. If you have concerns about your diet or lipid levels, please consult with a registered dietitian or your primary care physician to create a plan based on your clinical blood work.
Where can I find more information about APOE variants?
You can find reliable information about the APOE gene and its variants through resources like MedlinePlus Genetics or the NCBI Gene database. These sites provide comprehensive, evidence-based summaries of gene functions and associated health conditions.
Sources & further reading
Educational information only, last refreshed 10/11/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2477637?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in APOE
Variant in the APOE/TOMM40 locus associated with late-onset Alzheimer's disease risk.
Variant (c.497G>A, p.Arg166Gln) in the APOE gene known as Apolipoprotein E4 Christchurch, which has been shown in clinical case studies to confer resistance to familial Alzheimer's disease pathology.
Defines the APOE ε2 allele, associated with lower LDL cholesterol and reduced risk of Alzheimer's disease.
Upstream regulatory variant influencing APOE transcription and plasma lipid modulation.
Regulatory variant in the APOE promoter region modulating transcriptional activity and risk for late-onset neurodegeneration.
Variant in the APOE gene cluster strongly associated with low-density lipoprotein cholesterol levels and altered susceptibility to cardiovascular disease.